Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

The conclusion is that surgical removal of solitary fibrofolliculoma is effective with no relapses, and diagnosis requires a biopsy due to varied symptoms.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

A woman thought to have rosacea was actually suffering from Frontal Fibrosing Alopecia, a hair loss condition. Despite treatment, her condition didn't change, showing the importance of accurate early diagnosis.

Early diagnosis of frontal fibrosing alopecia is crucial to prevent permanent hair loss.

Frontal Fibrosing Alopecia might be an autoimmune disease.

The woman's skin and hair symptoms were confirmed as frontal fibrosing alopecia, and while facial papules are common in such cases, there's no effective local treatment, but systemic treatments can help.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Methotrexate may help stabilize frontal fibrosing alopecia.

A 15-year-old boy was correctly diagnosed with a rare skin condition after initially being misdiagnosed.

Skin changes in Pseudoxanthoma elasticum patients can indicate the severity of related health issues.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Frontal fibrosing alopecia is a complex condition with no definitive treatment.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

A 73-year-old woman with Hypopigmented Mycosis Fungoides, a rare skin lymphoma, experienced disease progression despite treatment, emphasizing the need for ongoing monitoring.

Early diagnosis and treatment can prevent or delay frontal fibrosing alopecia progression in postmenopausal women.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

Significant progress was made in understanding PXE, but effective treatments are still needed.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

A 10-year-old girl with Fox Fordyce disease improved with treatment, suggesting the disease can occur before puberty and might be underdiagnosed in young girls.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

The authors updated the criteria for diagnosing frontal fibrosing alopecia, making it easier to diagnose without a biopsy.

The patient had a severe itchy rash and hair loss in the armpits.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Fox Fordyce disease might be more common in prepubertal girls than thought and can be managed with treatment.